This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Andrew R. Harwood, MB, ChB; Douglas P. Bryce, MD; Walter D. Rider, MD, ChB

Arch Otolaryngol. 1980;106(11):697-699.

Abstract
• We reviewed 144 cases of T3NOMO glottic cancer. One hundred twelve patients were treated by radical radiotherapy with surgery for salvage (RRSS), and 28 patients were treated by combined preoperative irradiation and laryngectomy. Two patients underwent palliative irradiation, and two patients had surgery alone. Half of the number of patients are alive and well at five years; 30% of the patients died of glottic cancer. No significant difference in crude survival, tumor-related deaths, or deaths from surgical complications was observed between the RRSS group and the combined treatment group. The local control rate by radiotherapy was higher in female patients vs male patients (92% vs 44%); the local control rate was higher in men aged more than 60 years vs male patients who were younger than 60 years (52% vs 34%). Half of the larynges removed in the combined treatment group contained no tumor. We concluded that RRSS, because of its potential to save the larynx and voice, is the treatment of choice in female patients with T3 glottic cancer and is an acceptable alternative to combined treatment in male patients when good follow-up facilities exist.

(Arch Otolaryngol 106:697-699, 1980)

Author Affiliations
From the Department of Radiation Oncology, The Princess Margaret Hospital, Toronto (Drs Harwood and Rider), and the Department of Otolaryngology, University of Toronto (Dr Bryce).

Footnotes
Accepted for publication July 11, 1980.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, April 17, 1980.

Reprint requests to Department of Radiation Oncology, The Princess Margaret Hospital, 500 Sherbourne St, Toronto, Ontario M4X 1K9 Canada (Dr Harwood).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

T3 Glottic Carcinoma Revisited: Transglottic vs Pure Glottic Carcinoma
Hao et al.
Arch Otolaryngol Head Neck Surg 1995;121:166-170.
ABSTRACT  

Laryngeal Preservation for Advanced Laryngeal and Hypopharyngeal Cancers
Clayman et al.
Arch Otolaryngol Head Neck Surg 1995;121:219-223.
ABSTRACT  

The Treatment of T3 Glottic Carcinoma With Vertical Partial Laryngectomy
Kessler et al.
Arch Otolaryngol Head Neck Surg 1987;113:1196-1199.
ABSTRACT